SalubrisBio Secures $35M for Biologic Therapeutics Development
Key Highlights $35 million capital infusion to support SalubrisBio’s ongoing R&D in novel biologic therapeutics. Updates on clinical programs…
Browsing Tag
Salubris Biotherapeutics Inc.
1 post